Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00042536 · ClinicalTrials.gov registry record
Effects of Yohimbine and Naltrexone on Sexual Function
A clinical trial, sponsored by National Institute of Mental Health (NIMH).
- Completed
- Registry status
- 40
- Enrollment target
NCT00042536: Completed study, sponsored by National Institute of Mental Health (NIMH).
NCT00042536 is a clinical trial that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00042536 has completed, sponsored by National Institute of Mental Health (NIMH).
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and effectiveness of the drugs yohimbine and naltrexone in treating men with erectile dysfunction (ED) (the inability to achieve or maintain penile erection for satisfactory sexual performance). ED is a medical and psychological problem that is usually associated with increased age. Evidence suggests that specific neurotransmitter systems are involved in the regulation of sexual function. Yohimbine and naltrexone are drugs that may influence these neurotransmitter systems. This study will use different doses of yohimbine and fixed doses of naltrexone to determine their effectiveness in treating ED. Participants in this study will be screened with a medical history, physical examination, blood and urine tests, and an electrocardiogram (ECG). The study will consist of three outpatient visists.
Interventions
- DRUG Naltrexone HCL/ Yohimbine HCL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2002-07 |
| Est. Completion | 2004-04 |
What the finished NCT00042536 record still lists
NCT00042536 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Naltrexone HCL/ Yohimbine HCL is the first listed.
NCT00042536 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00042536 about?
NCT00042536 is a clinical study titled "Effects of Yohimbine and Naltrexone on Sexual Function". The purpose of this study is to evaluate the safety and effectiveness of the drugs yohimbine and naltrexone in treating men with erectile dysfunction (ED) (the inability to achieve or maintain penile erection for satisfactory sexual performance). ED is a medical and psychological problem that is us...
What is the current status of trial NCT00042536?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2002-07. Estimated completion is 2004-04.
What interventions are being tested in trial NCT00042536?
The interventions under investigation include: Naltrexone HCL/ Yohimbine HCL (DRUG).
Who is sponsoring clinical trial NCT00042536?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia